Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
[1] [2] It belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists , which were originally developed for type 2 diabetes management but have proven effective for weight loss at higher doses
Dapagliflozin reduced the primary composite outcome (sustained 50% eGFR decline, ESKD, or death from renal or cardiovascular causes) by 39% compared to placebo [47]
NAD+ in aging, metabolism, and neurodegeneration
Some community members report subjective improvements in energy and well-being during or shortly after a course
US$ 24.54
US$ 20.67
US$ 24.80
US$ 23.08
US$ 26.92
